A detailed history of Davis R M Inc transactions in Danaher Corp stock. As of the latest transaction made, Davis R M Inc holds 326,049 shares of DHR stock, worth $77.1 Million. This represents 1.78% of its overall portfolio holdings.

Number of Shares
326,049
Previous 329,882 1.16%
Holding current value
$77.1 Million
Previous $82.4 Million 9.97%
% of portfolio
1.78%
Previous 1.7%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$239.25 - $280.76 $917,045 - $1.08 Million
-3,833 Reduced 1.16%
326,049 $90.6 Million
Q2 2024

Aug 09, 2024

SELL
$235.51 - $267.98 $698,287 - $794,560
-2,965 Reduced 0.89%
329,882 $82.4 Million
Q1 2024

May 10, 2024

SELL
$224.58 - $256.19 $290,606 - $331,509
-1,294 Reduced 0.39%
332,847 $83.1 Million
Q4 2023

Feb 09, 2024

SELL
$185.1 - $233.13 $1.47 Million - $1.85 Million
-7,946 Reduced 2.32%
334,141 $77.3 Million
Q3 2023

Nov 14, 2023

SELL
$233.08 - $265.59 $2.16 Million - $2.46 Million
-9,249 Reduced 2.63%
342,087 $84.9 Million
Q2 2023

Aug 10, 2023

SELL
$224.99 - $256.14 $155,468 - $176,992
-691 Reduced 0.2%
351,336 $84.3 Million
Q1 2023

May 01, 2023

SELL
$239.75 - $277.0 $309,757 - $357,884
-1,292 Reduced 0.37%
352,027 $88.7 Million
Q4 2022

Feb 14, 2023

SELL
$241.42 - $282.29 $77,012 - $90,050
-319 Reduced 0.09%
353,319 $93.8 Million
Q3 2022

Nov 08, 2022

BUY
$247.06 - $1507.4 $1.66 Million - $10.1 Million
6,726 Added 1.94%
353,638 $91.3 Million
Q2 2022

Aug 08, 2022

BUY
$237.11 - $299.66 $183,997 - $232,536
776 Added 0.22%
346,912 $87.9 Million
Q1 2022

May 05, 2022

SELL
$257.27 - $315.76 $304,607 - $373,859
-1,184 Reduced 0.34%
346,136 $102 Million
Q4 2021

Feb 08, 2022

SELL
$292.08 - $329.01 $1.59 Million - $1.8 Million
-5,459 Reduced 1.55%
347,320 $114 Million
Q3 2021

Nov 08, 2021

SELL
$272.21 - $332.43 $2.71 Million - $3.31 Million
-9,965 Reduced 2.75%
352,779 $107 Million
Q2 2021

Aug 12, 2021

SELL
$225.08 - $271.69 $1.42 Million - $1.72 Million
-6,322 Reduced 1.71%
362,744 $97.3 Million
Q1 2021

May 10, 2021

SELL
$212.38 - $245.9 $2.03 Million - $2.35 Million
-9,543 Reduced 2.52%
369,066 $83.1 Million
Q4 2020

Jan 27, 2021

SELL
$212.5 - $245.46 $1.59 Million - $1.83 Million
-7,471 Reduced 1.94%
378,609 $84.1 Million
Q3 2020

Dec 01, 2020

SELL
$177.16 - $215.33 $983,415 - $1.2 Million
-5,551 Reduced 1.42%
386,080 $83.1 Million
Q2 2020

Jul 20, 2020

SELL
$128.7 - $176.83 $340,411 - $467,715
-2,645 Reduced 0.67%
391,631 $69.3 Million
Q1 2020

Apr 24, 2020

SELL
$121.39 - $169.05 $1.17 Million - $1.63 Million
-9,624 Reduced 2.38%
394,276 $54.6 Million
Q4 2019

Jan 23, 2020

SELL
$133.47 - $153.48 $704,054 - $809,607
-5,275 Reduced 1.29%
403,900 $62 Million
Q3 2019

Oct 24, 2019

SELL
$135.4 - $146.47 $356,779 - $385,948
-2,635 Reduced 0.64%
409,175 $59.1 Million
Q2 2019

Jul 31, 2019

SELL
$124.88 - $143.73 $827,205 - $952,067
-6,624 Reduced 1.58%
411,810 $58.9 Million
Q1 2019

Apr 29, 2019

SELL
$97.62 - $132.29 $538,276 - $729,447
-5,514 Reduced 1.3%
418,434 $55.2 Million
Q4 2018

Jan 18, 2019

BUY
$94.85 - $109.54 $505,360 - $583,629
5,328 Added 1.27%
423,948 $43.7 Million
Q3 2018

Oct 17, 2018

BUY
$98.13 - $108.9 $261,614 - $290,327
2,666 Added 0.64%
418,620 $45.5 Million
Q2 2018

Jul 19, 2018

BUY
$96.1 - $103.24 $278,401 - $299,086
2,897 Added 0.7%
415,954 $41 Million
Q1 2018

Apr 19, 2018

BUY
$92.16 - $103.8 $428,267 - $482,358
4,647 Added 1.14%
413,057 $40.4 Million
Q4 2017

Jan 16, 2018

BUY
$85.26 - $94.62 $187,486 - $208,069
2,199 Added 0.54%
408,410 $37.9 Million
Q3 2017

Oct 24, 2017

BUY
$79.29 - $88.45 $32.2 Million - $35.9 Million
406,211
406,211 $34.8 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Davis R M Inc Portfolio

Follow Davis R M Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis R M Inc, based on Form 13F filings with the SEC.

News

Stay updated on Davis R M Inc with notifications on news.